Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to New Levothyroxine Formulation in Thyroidectomised Patients
NCT01916304Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levothyroxine sodium in hypothyroidism, sponsored by Takeda. Started Jul 2013; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT01916304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916304.